Form D · Biotechnology
Opus KSD, Inc.
Pembroke, MA · CIK 0001668934
Offering snapshot reported Oct 1, 2026 · SEC filing
- Reported sold
- $681K Offering amount: $681K
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Sep 23, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 1, 2026 | Initial | $680,801 | No comparison | 16 | SEC filing |
| Oct 31, 2023 | Initial | $300,000 | No comparison | 3 | SEC filing |
| Mar 8, 2016 | Initial | $500,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-599665
Source: Form D, filed Oct 1, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Saud Abdulaziz Al Turki | Director |
| Saud Alturki | Director |
| Porter Anderson | Director |
| Kenneth Danielson | Director |
| Christos Monovoukas | Director |
| Charles Rogers | Director |
| Wei Shen | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
50 Corporate Park Dr. Suite 710
Pembroke, MA, 02359
Phone: 781-929-7406
Pembroke, MA, 02359
Phone: 781-929-7406